Atrial fibrillation

Atrial fibrillation is a serious cardiac arrhythmia characterized by rapid, chaotic electrical activity in the heart's upper chambers (atria), resulting in an irregular and often abnormally fast heartbeat. In cats, this condition is relatively uncommon compared to dogs, but when it occurs, it almost always indicates the presence of significant underlying heart disease. During atrial fibrillation, the atria quiver ineffectively rather than contracting in a coordinated manner, which disrupts normal blood flow through the heart and can significantly compromise cardiac function. The irregular ventricular response that results from the chaotic atrial activity produces the characteristically irregular pulse that veterinarians detect during physical examination.

The development of atrial fibrillation in cats is almost invariably associated with severe structural heart disease that has caused significant enlargement of the atria. Hypertrophic cardiomyopathy is the most common underlying condition, though dilated cardiomyopathy, restrictive cardiomyopathy, and unclassified cardiomyopathies can also predispose cats to this arrhythmia. The enlarged atrial tissue provides the substrate for the abnormal electrical circuits that sustain fibrillation. Unlike in some human patients where atrial fibrillation may occur in otherwise healthy hearts (lone atrial fibrillation), this presentation is extremely rare in cats, making the detection of atrial fibrillation an important indicator that serious cardiac pathology exists.

The impact of atrial fibrillation on affected cats can be substantial, as the arrhythmia itself worsens the cardiac dysfunction already present from underlying heart disease. The loss of effective atrial contraction reduces the heart's filling efficiency by approximately 15-25 percent, which further compromises cardiac output in hearts already struggling with cardiomyopathy. Rapid ventricular rates that often accompany uncontrolled atrial fibrillation put additional strain on the heart muscle and can accelerate the progression of heart failure. The irregular blood flow patterns created by the arrhythmia also increase the risk of blood clot formation within the atria, potentially leading to arterial thromboembolism, one of the most devastating complications of feline heart disease.

Treatment of atrial fibrillation in cats focuses on controlling the ventricular rate to improve cardiac function and managing the underlying heart disease that caused the arrhythmia to develop. Unlike in some human and canine patients, converting cats from atrial fibrillation back to normal sinus rhythm is rarely successful long-term, so treatment typically aims for rate control rather than rhythm control. With appropriate management, some cats with atrial fibrillation can achieve reasonable quality of life, though the presence of this arrhythmia generally indicates advanced cardiac disease and carries important prognostic implications. Regular veterinary monitoring is essential to optimize treatment and detect complications early.

The primary cause of atrial fibrillation in cats is severe underlying structural heart disease that results in significant atrial enlargement. When the atria become markedly dilated, the stretched cardiac tissue develops abnormal electrical properties that predispose to chaotic rhythm disturbances. The normal organized electrical conduction through the atrial tissue becomes disrupted, allowing multiple small reentrant circuits to develop and sustain the fibrillation. In cats, atrial fibrillation almost never occurs without pre-existing heart disease, making it an important marker of advanced cardiac pathology. The threshold degree of atrial enlargement required to support sustained fibrillation explains why this arrhythmia tends to appear in the later stages of progressive cardiomyopathy.

Hypertrophic cardiomyopathy (HCM) represents the most common underlying condition associated with atrial fibrillation in cats. The thickened, stiff ventricle characteristic of HCM impairs filling during diastole, leading to elevated pressures that are transmitted back to the left atrium. Over time, this chronic pressure overload causes progressive left atrial dilation. When the atrium reaches a critical size, the electrical substrate becomes favorable for fibrillation to develop. Other forms of cardiomyopathy, including dilated, restrictive, and unclassified cardiomyopathy, can similarly cause the severe atrial enlargement that predisposes to atrial fibrillation. The specific cardiomyopathy type matters less than the resulting atrial dilation.

Certain conditions beyond primary cardiomyopathy can contribute to atrial fibrillation development in cats. Hyperthyroidism, common in older cats, causes cardiac changes including increased heart rate and potential for atrial dilation that may predispose to arrhythmias. Systemic hypertension increases cardiac workload and can contribute to atrial enlargement over time. Severe anemia forces the heart to work harder to deliver oxygen, potentially stressing atrial tissue. Chronic volume overload from congenital heart defects such as patent ductus arteriosus or mitral valve dysplasia can cause the atrial dilation needed for fibrillation to develop. Any condition that significantly enlarges the atria creates risk for this arrhythmia.

Risk factors for developing atrial fibrillation relate primarily to the severity and duration of underlying heart disease. Age is relevant because cardiomyopathy tends to progress over time, with more advanced disease and greater atrial enlargement in older affected cats. Cats with more severe echocardiographic findings, particularly marked left atrial dilation, are at higher risk compared to those with milder changes. A history of congestive heart failure indicates advanced disease stage and increased fibrillation risk. Uncontrolled hyperthyroidism in cats with concurrent cardiac disease may accelerate arrhythmia development. Male cats may be slightly overrepresented among those developing atrial fibrillation, possibly reflecting higher cardiomyopathy prevalence.

The electrophysiological mechanism of atrial fibrillation involves complex interactions between abnormal atrial tissue and triggers that initiate the arrhythmia. In dilated atria, areas of fibrosis and electrical heterogeneity create regions where conduction velocity varies, allowing multiple small wavelet reentry circuits to form and perpetuate. Triggers such as premature atrial contractions can initiate fibrillation in susceptible tissue. Once established, the chaotic electrical activity becomes self-sustaining as the multiple wavelet reentry continues. The rapid, irregular impulses bombard the atrioventricular node, which conducts them irregularly to the ventricles, producing the characteristically irregular ventricular rhythm. Understanding this mechanism explains why restoring normal rhythm is so difficult once fibrillation becomes established.

Early warning signs of atrial fibrillation in cats can be difficult to distinguish from symptoms of the underlying heart disease that invariably precedes this arrhythmia. Because atrial fibrillation in cats almost always develops in the context of advanced cardiomyopathy, many cats are already showing signs of heart disease before the arrhythmia appears. Owners may notice their cat seems to have worsened suddenly, with a decline in activity level or appetite that seems disproportionate to the gradual progression they had observed previously. This acute deterioration can reflect the additional hemodynamic burden imposed when atrial fibrillation develops. Some cats may exhibit increased respiratory rate or effort as the arrhythmia compromises cardiac function and contributes to fluid accumulation.

The common symptoms associated with atrial fibrillation largely overlap with those of congestive heart failure, as the two conditions frequently coexist. Rapid, labored breathing is often the most prominent sign, reflecting pulmonary edema or pleural effusion that develops when the failing heart cannot effectively pump blood forward. Open-mouth breathing, which is always abnormal in cats, indicates severe respiratory compromise requiring immediate attention. Affected cats may adopt unusual postures to ease breathing, such as sitting upright with elbows abducted or extending the neck and head forward. Some cats cough, though this is less common in feline heart disease than in dogs. Exercise intolerance or reluctance to engage in normal activities reflects the heart's inability to increase output appropriately.

Behavioral changes in cats with atrial fibrillation reflect their overall declining health status and cardiovascular compromise. Decreased appetite is extremely common and may result from nausea associated with poor perfusion, difficulty breathing while eating, or general malaise. Weight loss accompanies reduced food intake and may become substantial in cats with advanced disease. Affected cats often become withdrawn and socially isolated, spending more time hiding and less time interacting with family members. Reduced grooming activity leads to an unkempt, dull coat. Lethargy and weakness are prominent, with cats sleeping more and showing little interest in activities they previously enjoyed.

Physical signs detectable during examination provide important diagnostic clues in cats with atrial fibrillation. The hallmark finding is an irregular pulse that varies in strength from beat to beat, reflecting the chaotic ventricular response to the fibrillating atria. The heart rate is often rapid, potentially exceeding 240 beats per minute in uncontrolled cases. A heart murmur may be present from the underlying cardiomyopathy, and gallop sounds sometimes accompany the irregular rhythm. Muffled heart sounds can indicate pleural effusion. Pale or cyanotic mucous membranes suggest inadequate tissue perfusion. Jugular venous distension or pulses may be visible in cats with elevated right heart pressures.

Symptom progression in cats with atrial fibrillation depends on both the severity of underlying heart disease and how well the ventricular rate can be controlled with treatment. Some cats experience acute deterioration when fibrillation first develops, with sudden worsening of respiratory effort and exercise tolerance. Others may develop the arrhythmia more insidiously, with gradual decline over weeks. Episodic decompensation characterized by pulmonary edema or pleural effusion commonly punctuates the disease course, requiring periodic treatment intensification. The irregular nature of the heartbeat means cardiac output varies substantially from beat to beat, contributing to moment-to-moment variability in how the cat feels and functions.

Emergency symptoms that require immediate veterinary attention include severe respiratory distress with open-mouth breathing, gasping, or cyanosis. Collapse or weakness too profound to stand warrants urgent evaluation. Sudden onset of rear limb paralysis with painful, cold legs indicates arterial thromboembolism, a common and devastating complication of feline heart disease that is particularly associated with atrial fibrillation due to the blood stasis in the fibrillating atria. Acute deterioration in a cat known to have heart disease should never be ignored. Because cats are adept at hiding illness, by the time obvious symptoms appear, the situation is often serious and requires prompt professional evaluation.

The diagnosis of atrial fibrillation in cats typically begins when a veterinarian detects an irregular heartbeat during routine physical examination or when evaluating a cat with symptoms of cardiac disease. Auscultation with a stethoscope reveals the characteristically irregular heart rhythm, often with variation in the intensity of heart sounds from beat to beat and a rapid rate. The irregular pulse can be confirmed by palpating the femoral artery and noting the variable pulse strength and irregular intervals. A pulse deficit, where some heartbeats are too weak to produce a palpable pulse, may be present. The physical examination also assesses for signs of underlying heart disease and congestive heart failure, including respiratory abnormalities, heart murmurs, and evidence of fluid accumulation.

Electrocardiography (ECG) provides definitive confirmation of atrial fibrillation and should be performed in any cat with a suspected irregular rhythm. The classic ECG findings in atrial fibrillation include absence of organized P waves (which represent normal atrial contraction), replacement of P waves with irregular fibrillatory waves (f waves), and an irregularly irregular ventricular response (varying R-R intervals). The ventricular rate in cats with atrial fibrillation is typically rapid, often exceeding 200 beats per minute without treatment. The ECG also identifies any concurrent arrhythmias or conduction disturbances that may influence treatment decisions. A Holter monitor, which records the ECG continuously over 24 hours, may occasionally be used to characterize rhythm variations over time.

Echocardiography is essential for evaluating the underlying heart disease that caused atrial fibrillation to develop. Because atrial fibrillation in cats virtually always indicates significant structural heart disease, cardiac ultrasound reveals the nature and severity of cardiomyopathy present. Marked left atrial dilation is the consistent finding, as this provides the substrate for fibrillation. The echocardiogram characterizes ventricular wall thickness, chamber dimensions, and contractile function, allowing classification of the underlying cardiomyopathy. Doppler evaluation assesses blood flow patterns and can estimate filling pressures. Importantly, echocardiography identifies spontaneous echo contrast (swirling smoke-like patterns) or formed thrombus within the enlarged atria, which indicates high thromboembolism risk.

Additional diagnostic testing helps complete the evaluation and guide treatment for cats with atrial fibrillation. Blood tests including complete blood count, biochemistry panel, and thyroid hormone levels identify concurrent conditions such as hyperthyroidism that may contribute to or complicate the arrhythmia. Cardiac biomarkers including NT-proBNP and cardiac troponin I provide information about cardiac stress and damage. Thoracic radiographs evaluate heart size, pulmonary vasculature, and the presence of pulmonary edema or pleural effusion. Blood pressure measurement identifies hypertension that requires treatment. Together, these tests create a comprehensive picture of the cat's cardiovascular status and identify factors that influence prognosis and treatment approach.

Emergency treatment for cats with atrial fibrillation and acute heart failure prioritizes stabilization and relief of life-threatening symptoms. Cats presenting in respiratory distress receive supplemental oxygen while stress is minimized, as anxiety significantly increases oxygen demand and can worsen the situation. If pleural effusion is causing respiratory compromise, thoracocentesis provides rapid relief by draining fluid from around the lungs. Furosemide, a potent diuretic, reduces pulmonary edema and venous congestion. Rate control to slow the rapid ventricular response may begin in the emergency setting, though this must be approached carefully in hemodynamically unstable patients. Sedation may be necessary to reduce anxiety and improve oxygenation in severely distressed cats.

Rate control represents the cornerstone of medical management for atrial fibrillation in cats. Unlike rhythm control strategies that attempt to restore normal sinus rhythm, rate control accepts the persistence of fibrillation while using medications to slow the ventricular response to a more physiologically tolerable range. Diltiazem, a calcium channel blocker, is commonly used for rate control in cats and slows conduction through the atrioventricular node to reduce ventricular rate. Beta-blockers such as atenolol provide an alternative or additional option for rate control. The target ventricular rate varies but generally aims for rates below 180-200 beats per minute while maintaining adequate cardiac output. Finding the optimal medication and dose for each individual cat often requires careful titration.

Managing underlying heart disease and congestive heart failure is equally important as controlling the arrhythmia itself. Diuretics, primarily furosemide, remain essential for cats with fluid accumulation from heart failure. ACE inhibitors may provide additional benefit by reducing cardiac workload. Treatment of concurrent conditions such as hyperthyroidism is necessary if present, as controlling thyroid hormone levels helps manage the cardiac manifestations. The comprehensive management plan addresses all aspects of the cat's cardiovascular disease rather than focusing solely on the rhythm disturbance. Regular monitoring and medication adjustment optimize outcomes over time.

Anticoagulant therapy is critically important in cats with atrial fibrillation because the arrhythmia significantly increases thromboembolism risk. The enlarged, fibrillating atria create conditions where blood stagnates and clots can form, potentially leading to devastating arterial thromboembolism if these clots dislodge. Clopidogrel (Plavix) is the most commonly prescribed antiplatelet medication for cats at high thrombotic risk. Some cardiologists additionally recommend low-dose aspirin, though the benefit of dual antiplatelet therapy must be weighed against increased bleeding risk. The presence of spontaneous echo contrast or formed thrombus on echocardiography strengthens the indication for aggressive anticoagulation.

Cardioversion to restore normal sinus rhythm is rarely successful in cats with atrial fibrillation, unlike in some human and canine patients. Because feline atrial fibrillation occurs in the setting of severe structural heart disease with marked atrial enlargement, the substrate that sustains the arrhythmia persists even if momentary conversion is achieved. Chemical cardioversion attempts are generally unsuccessful, and electrical cardioversion, while technically possible, typically results in immediate or rapid recurrence of fibrillation. For these reasons, rhythm control strategies are not routinely pursued in cats, and treatment focuses instead on rate control and managing underlying disease.

Treatment decisions for cats with atrial fibrillation require honest discussions about prognosis and realistic expectations. The presence of atrial fibrillation indicates advanced cardiac disease with limited long-term outlook compared to cats with earlier-stage cardiomyopathy. However, some cats respond well to rate control and heart failure management, achieving reasonable quality of life for months or occasionally longer. Multiple medications given several times daily may be required, which poses practical challenges for some owners and cats. Financial costs of ongoing cardiac care accumulate over time. Understanding that atrial fibrillation represents a significant milestone in the progression of heart disease helps families make informed decisions about their cat's care.

Recovery and stabilization for cats newly diagnosed with atrial fibrillation depends heavily on the severity of concurrent heart failure and the response to rate control therapy. Cats hospitalized for acute decompensation typically require two to five days of intensive care, with some needing longer stays for refractory cases. Initial improvement in respiratory comfort from diuretic therapy and fluid removal often occurs within the first 24-48 hours. Rate control medications may take several days to achieve their full effect, and dose adjustments are common during the initial stabilization period. Frequent monitoring of heart rate, respiratory rate, and overall clinical status guides treatment modifications during hospitalization.

Post-treatment care after hospital discharge involves ongoing medication administration and home monitoring to maintain stability. Most cats with atrial fibrillation require multiple medications given daily, including rate control agents, diuretics, and anticoagulants. Establishing a consistent medication schedule helps ensure compliance. Activity restriction is generally recommended, with affected cats kept indoors and discouraged from exertion. Monitoring resting respiratory rate at home provides valuable early warning of fluid reaccumulation, with consistently elevated rates above 40 breaths per minute warranting veterinary contact. Follow-up appointments allow assessment of rate control adequacy and overall disease status, typically scheduled every few weeks initially then less frequently for stable patients.

The prognosis for cats with atrial fibrillation is generally guarded because the arrhythmia indicates advanced underlying heart disease. Survival times vary considerably depending on the severity of cardiomyopathy, response to treatment, and development of complications. Some cats achieve good rate control and maintain reasonable quality of life for several months to occasionally over a year. Others experience more rapid decline despite appropriate therapy. Factors associated with poorer prognosis include severe left atrial enlargement, presence of spontaneous echo contrast or thrombus, refractory heart failure, and occurrence of thromboembolism. The unpredictable nature of feline heart disease progression means individual outcomes vary substantially from statistical averages.

Long-term outlook for cats living with atrial fibrillation requires balancing realistic expectations with hope for quality time. While the arrhythmia cannot be cured and the underlying heart disease will likely progress, many cats enjoy comfortable periods between episodes of decompensation. Focusing on quality of life day by day, rather than predicted survival statistics, helps families make the most of their time together. Recurrent congestive heart failure episodes are common and typically require treatment adjustments. Eventually, progressive disease or complications such as thromboembolism affect most cats with atrial fibrillation. Planning for end-of-life care and discussing quality of life assessment with the veterinary team should begin early in the disease course.

Primary prevention of atrial fibrillation in cats is inherently linked to preventing or managing the underlying heart disease that causes this arrhythmia to develop. Because atrial fibrillation virtually always occurs secondary to severe structural heart disease with marked atrial enlargement, strategies that prevent cardiomyopathy progression or detect heart disease early offer the best opportunity to reduce fibrillation risk. Unfortunately, the underlying cardiomyopathies themselves often cannot be prevented when they arise from genetic predisposition. However, early detection through screening and appropriate management may slow disease progression and delay or prevent the severe atrial dilation that provides the substrate for fibrillation.

Environmental and lifestyle factors that support overall cardiovascular health may provide indirect benefit in reducing cardiac disease progression. Maintaining cats at ideal body weight reduces cardiovascular strain. Providing high-quality nutrition that meets all essential requirements supports cardiac function. Minimizing chronic stress through environmental enrichment and stable routines may reduce ongoing cardiovascular demand. Keeping cats indoors reduces exposure to infectious diseases that could potentially cause myocardial damage. Avoiding exposure to secondhand smoke eliminates one potential cardiovascular stressor. While these measures cannot prevent genetic cardiomyopathy, they support overall health and may slow disease progression.

Dietary prevention specifically targeting cardiac health focuses on ensuring adequate intake of nutrients essential for heart function. Taurine, an amino acid required by cats, is critical for cardiac muscle health and is provided in appropriate amounts by quality commercial cat foods. Omega-3 fatty acids may have beneficial effects on cardiac function and inflammation. Avoiding excessive sodium intake is generally recommended for cats with known heart disease. Maintaining lean body condition through appropriate caloric intake prevents obesity-related cardiovascular stress. Fresh, clean water should always be available to maintain adequate hydration.

Regular veterinary care and cardiac screening enable early detection of heart disease before it progresses to the point where atrial fibrillation can develop. Annual or biannual wellness examinations include cardiac auscultation that may detect murmurs or arrhythmias indicating heart disease. Cats belonging to breeds with known cardiomyopathy predisposition benefit from periodic echocardiographic screening even in the absence of clinical findings. Early identification of cardiomyopathy allows treatment initiation before severe atrial enlargement develops. Managing identified risk factors such as hyperthyroidism and hypertension appropriately may reduce cardiac stress and slow disease progression.

Early intervention when heart disease is diagnosed offers the best opportunity to prevent or delay complications including atrial fibrillation. Cats with preclinical cardiomyopathy may benefit from early treatment that reduces cardiac workload and potentially slows remodeling. Aggressive management of hyperthyroidism in affected cats prevents thyroid-related cardiac changes from contributing to cardiomyopathy progression. Control of systemic hypertension reduces the additional burden on an already compromised heart. Regular echocardiographic monitoring tracks disease progression and identifies increasing atrial size that signals heightened arrhythmia risk. While atrial fibrillation cannot always be prevented in cats with progressive cardiomyopathy, optimal management of the underlying disease provides the best chance.

Daily management of a cat with atrial fibrillation requires commitment to medication administration and careful monitoring of clinical status. Multiple medications are typically required, including rate control drugs, diuretics, anticoagulants, and potentially other cardiac medications, often given at different intervals throughout the day. Establishing a consistent schedule that integrates medication times into daily routines improves compliance and ensures doses are not missed. Pill pockets, compounded flavored liquids, or transdermal formulations can make medicating easier for difficult cats. A medication log helps track doses and provides useful information for veterinary visits. Monitoring resting respiratory rate daily, ideally when the cat is sleeping or completely relaxed, provides valuable warning of potential fluid reaccumulation.

Home environment modifications enhance comfort and reduce unnecessary exertion for cats with atrial fibrillation. Essential resources including food, water, and litter boxes should be easily accessible on a single floor to eliminate stair climbing. Comfortable, padded resting areas in quiet locations allow undisturbed rest. Temperature control matters because both heat and cold stress the cardiovascular system. Minimizing environmental stressors such as loud noises, unfamiliar visitors, or conflicts with other pets helps keep cats calm. Providing hiding spaces where cats can retreat when feeling unwell respects their natural coping behaviors. Synthetic feline pheromone products may help reduce anxiety in some cats.

Maintaining quality of life for cats with atrial fibrillation balances necessary restrictions with opportunities for enjoyment and enrichment. While strenuous activity should be avoided, gentle interactive play appropriate to the cat's energy level provides mental stimulation without overtaxing the heart. Window perches for watching outdoor activity offer entertainment without physical exertion. Puzzle feeders encourage mental engagement during meals. Regular gentle grooming maintains coat health and provides positive social interaction. The goal is maximizing comfortable, enjoyable days while respecting the limitations imposed by the heart condition. Many cats adapt well to a quieter lifestyle and continue to find pleasure in their daily routines.

Ongoing monitoring and communication with the veterinary team are essential for cats with atrial fibrillation. Learning to recognize signs of deterioration enables prompt intervention that may prevent full decompensation. Changes in respiratory rate or effort, decreased appetite, increased lethargy, or reluctance to move warrant veterinary contact. A home diary tracking daily observations helps identify trends and provides valuable information for recheck appointments. Regular follow-up visits, typically every one to three months for stable patients, allow assessment of rate control adequacy and overall disease status. Knowing when and how to access emergency veterinary care prepares families for potential crises.

Caregiver support matters throughout the journey of managing a cat with serious heart disease. The emotional toll of caring for a chronically ill pet, combined with practical demands of complex medication schedules, can be substantial. Connecting with online communities of cat owners managing similar conditions provides support and shared experiences. Open communication with the veterinary team about concerns, challenges, and treatment goals ensures everyone works toward the same objectives. Financial planning for ongoing care expenses reduces stress about treatment decisions. Recognizing that quality of life considerations apply to the entire family, including human caregivers, helps maintain everyone's ability to provide excellent care.

Atrial fibrillation in cats is not directly associated with specific breed predispositions but rather occurs as a consequence of advanced underlying heart disease, particularly the various cardiomyopathies. Therefore, breeds predisposed to developing cardiomyopathy may have indirect increased risk of eventually developing atrial fibrillation if their heart disease progresses to cause severe atrial enlargement. Maine Coon cats, which have well-documented genetic predisposition to hypertrophic cardiomyopathy, may be at elevated risk for developing atrial fibrillation as a late complication of progressive HCM. Ragdoll cats, another breed with known HCM susceptibility, similarly could face increased atrial fibrillation risk. Other breeds occasionally reported with cardiomyopathy associations include British Shorthairs, Persians, and Sphynx cats.

Domestic shorthair and domestic longhair cats account for many feline atrial fibrillation cases, reflecting both their population prevalence and the fact that cardiomyopathy affects cats of all backgrounds. Mixed-breed cats with ancestry from high-risk purebred lines may carry inherited cardiac disease susceptibility. The critical factor determining atrial fibrillation risk is not breed per se but rather the presence and severity of underlying cardiomyopathy and resulting atrial dilation. Any cat that develops advanced heart disease with significant atrial enlargement faces the potential for atrial fibrillation regardless of breed. The connection between breed and atrial fibrillation is therefore indirect, mediated through cardiomyopathy susceptibility.

Screening recommendations focus on early detection of underlying cardiomyopathy rather than atrial fibrillation specifically. Breeds with known HCM predisposition benefit from periodic echocardiographic screening, ideally beginning before breeding age in cats intended for reproduction. Genetic testing for specific HCM mutations is available for Maine Coons and Ragdolls and can identify affected or carrier cats. All cats benefit from cardiac auscultation during routine veterinary examinations, which may detect murmurs or irregular rhythms warranting further evaluation. Cats diagnosed with cardiomyopathy should receive regular echocardiographic monitoring to track disease progression and identify increasing atrial size that elevates fibrillation risk. Early identification and management of heart disease offers the best opportunity to delay or prevent progression to atrial fibrillation.

Atrial fibrillation in cats is fundamentally linked to underlying structural heart disease, most commonly the various forms of cardiomyopathy. Hypertrophic cardiomyopathy, the most prevalent feline heart disease, accounts for many atrial fibrillation cases when it progresses to cause severe left atrial dilation. Dilated cardiomyopathy, restrictive cardiomyopathy, and unclassified cardiomyopathy can similarly lead to atrial fibrillation as complications of advanced disease. Congestive heart failure commonly coexists with atrial fibrillation, as both conditions reflect severe cardiac dysfunction. Hyperthyroidism, particularly common in older cats, may contribute to cardiac changes and increase arrhythmia risk. Systemic hypertension adds to cardiac workload and can accelerate cardiomyopathy progression.

Several other cardiac arrhythmias may occur alongside or be confused with atrial fibrillation in cats. Atrial flutter, a related supraventricular arrhythmia, produces a more organized but still rapid atrial rhythm that can resemble fibrillation. Other supraventricular tachycardias may produce rapid heart rates but typically maintain regularity unlike the characteristic irregularity of atrial fibrillation. Ventricular arrhythmias including premature ventricular complexes and ventricular tachycardia may occur concurrently with atrial fibrillation or independently in cats with heart disease. Conduction disturbances such as atrioventricular block can develop in cats with advanced cardiac disease. Accurate identification of the specific arrhythmia through electrocardiography guides appropriate treatment selection.

Arterial thromboembolism represents the most devastating complication associated with atrial fibrillation in cats. The fibrillating, enlarged atria create conditions of blood stasis that promote thrombus formation. If these clots dislodge and travel through the bloodstream, they typically lodge at the aortic bifurcation (saddle thrombus), blocking blood supply to the rear legs and causing acute paralysis, severe pain, and limb coldness. Thromboembolism carries a grave prognosis and causes significant suffering. The heightened thromboembolism risk in cats with atrial fibrillation underscores the importance of anticoagulant therapy. Other complications of atrial fibrillation include progressive heart failure, kidney disease from reduced cardiac output, and sudden cardiac death from associated ventricular arrhythmias.